Difference between revisions of "Atypical fibroxanthoma"

Jump to navigation Jump to search
(+images)
Line 76: Line 76:
**Scant staining not considered +ve.
**Scant staining not considered +ve.
*Desmin -ve (done to r/o leiomyosarcoma).
*Desmin -ve (done to r/o leiomyosarcoma).
Others:
*Vimentin +ve.
*SMA +ve.{{fact}}
New ''et al.'' suggests:<ref name=pmid20713774>{{Cite journal  | last1 = New | first1 = D. | last2 = Bahrami | first2 = S. | last3 = Malone | first3 = J. | last4 = Callen | first4 = JP. | title = Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature. | journal = Arch Dermatol | volume = 146 | issue = 12 | pages = 1399-404 | month = Dec | year = 2010 | doi = 10.1001/archdermatol.2010.206 | PMID = 20713774 }}</ref>
*Vimentin, SMA, CD68, cytokeratins, p63, desmin, CD99, CD10, S-100, CD117, LN-2, procollagen I.
A panel:
*Vimentin, SMA, CD68, CK18, EMA, CAM5.2, CK34betaE12, CK5/6, p63, desmin, CD99, CD10, S100, CD34.


==Sign out==
==Sign out==
48,835

edits

Navigation menu